Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,323 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A 70/30 portfolio looks conservative on paper, but the 2022 stress test exposes a $187,000 shortfall on a $2.1 millio...
X-Energy lands ratings from six major firms, with five Buy or Overweight calls and a top target of $57, as investors ...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
ARK’s latest AI IPO move put Cerebras at the center of a hype-filled market. Before you copy a big bet, learn the rea...
Nvidia approaches Q1 FY2027 with lofty guidance and heightened scrutiny, as wall street holds breath awaiting whether...
Oracle rides a rebound in AI spending with a hefty backlog and cloud growth; a 12-month target suggests meaningful up...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...
Investors are eyeing a possible SpaceX IPO, with a prospectus that analysts say could redefine how a private tech emp...
The market presses higher as investors cling to earnings resilience and policy stability, with AI and defense leading...
Regulators and banks frame XRP's path as traders debate a remote target. This report lays out what would be required ...
Rocket Mortgage and Rocket Pro are rolling out VantageScore 4.0 in the mortgage qualification process, pairing it wit...